Showing results (1-10 of 33) with videos related to
Sort By:
Pageof 4
Human Vaccines & Immunotherapeutics|August 3, 2012
Inter-tumor heterogeneityMike Cusnir, Ludmila CavalcanteCancer Journal (Sudbury, Mass.)|May 8, 2004
Novel systemic therapy options for hepatocellular carcinomaMike Cusnir, Yehuda Z PattClinical Advances in Hematology & Oncology : H&O|May 28, 2024
Improving survival in metastatic colorectal cancer through optimized patient selectionTanios S Bekaii-Saab, Afsaneh Barzi, Mike CusnirCase Reports in Oncology|February 1, 2012
Typical bronchial carcinoid metastasizing to the brain: a case presentationSimon B Zeichner, Mike Cusnir, Michael Francavilla, et al.Case Reports in Oncological Medicine|May 11, 2013
Gastric small-cell carcinoma found on esophagogastroduodenoscopy: a case report and literature reviewNatassja Frances, Simon B Zeichner, Michael Francavilla, et al.Clinical Medicine Insights. Oncology|November 2, 2012
A De Novo Germline APC Mutation (3927del5) in a Patient with Familial Adenomatous Polyposis: Case Report and Literature ReviewSimon B Zeichner, Naveen Raj, Mike Cusnir, et al.Journal of Investigative Medicine High Impact Case Reports|October 30, 2016
An Occult Malignancy Behind a Demyelinating Disease: POEMS SyndromeSaberio Lo Presti, Prashanth Kanagarajah, Daniela Pirela, et al.Pathology, Research and Practice|August 23, 2020
Retinoblastoma co-repressor 1 (RB) and cyclin-dependent kinase inhibitor (CDKN) as a multi-gene panel for differentiating pulmonary from non-pulmonary origin in metastatic neuroendocrine carcinomasKritika Krishnamurthy, Mike Cusnir, Michael Schwartz, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 28, 2010
Phase II trial of combined modality therapy with myeloid growth factor support in patients with locally advanced non-small cell lung cancerRogerio Lilenbaum, Michael Samuels, Michele Taffaro-Neskey, et al.Breast Disease|May 31, 2022
ROS1 altered breast cancers - a distinctive molecular subtype of PR- metastatic breast cancers: Expanding the scope of targeted therapeuticsKritika Krishnamurthy, Arunima Deb, Sarah Alghamdi, et al.Pageof 4